Fred Poordad

5PUBLICATIONS
2CO-AUTHORS
Medical biochemistry - lipidsPredictive and prognostic markersSocial determinants of healthHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 22, 2026
Liver Biopsy in Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials: Potential Pitfalls and Solutions.

|Apr 28, 2025
The accuracy of FibroScan, FIB-4, and nonalcoholic fatty liver disease fibrosis score in predicting biopsy-defined fibrosis and steatosis across all fibrosis stages in patients with metabolic dysfunction associated steatotic liver disease.

Keerthi Thallapureddy, David Twitchell, Kristen Ott

|Jan 31, 2024
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH.

Naim Alkhouri, Carl LaCerte, Jeffrey Edwards

|Jul 28, 2023
High sustained virologic response rates, regardless of race or socioeconomic class, in patients treated with chronic hepatitis C in community practice using a specialized pharmacy team.

Saatchi Kuwelker, Eugenia Tsai, Lily Kuo

|Feb 13, 2020
Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies.

Fred Poordad, Norah A Terrault, Naim Alkhouri

Pageof 1

Frequent Collaborators

2 joint publications

Eric Lawitz

1 joint publications

Naim Alkhouri